Background-Aminolaevulinic acid (ALA) is an endogenous substrate in the haem biosynthetic pathway. Protoporphyrin IX (PPIX), the immediate haem precursor in the pathway, has photoexcitable properties. Exogenous ALA has been used previously as a precursor agent in photodynamic therapy (PDT). Its main advantage is a short half-life and hence reduced incidence of skin photosensitivity. ALA can be toxic, however, causing, for example, transient increases in liver enzyme concentrations when given systemically and this may be dose related. Aim-To assess whether accumulation of PPIX and ultimately the efficacy of PDT could be improved by modulating both ends of the haem biosynthetic pathway. Methods-Gastric cancer cells (MKN 28) were incubated with ALA (0-1000 ,umolar) and desferrioxamine (0-800 ,umolar) for 24 hours before exposure to argonpumped dye laser (630 nm) at different energy levels (0-40 J/cm2). Cell viability was assessed by use of the methyl-tetrazolium (MTT) assay four hours after exposure to light. Results-Total PPIX accumulation increased linearly with increasing extracellular concentrations of ALA up to 1 mmolar (r=0.973, p<0005). Adding 200 molar of desferrioxamine trebled PPIX accumulation over the same period of incubation. Cell viability after exposure to light decreased with low doses (0-30 ,umolar) of desferrioxamine (r--0.976, p=0.024). However, higher doses of desferrioxamine (more than 40 molar) seemed to confer a protective effect against PDT. Conclusion-PDT using ALA can be improved by removal of available iron with desferrioxamine. The reason for the protective effect of desferrioxamine seen at higher doses is not clear.
pumped dye laser (630 nm) at different energy levels (0-40 J/cm2). Cell viability was assessed by use of the methyl-tetrazolium (MTT) assay four hours after exposure to light. Results-Total PPIX accumulation increased linearly with increasing extracellular concentrations of ALA up to 1 mmolar (r=0.973, p<0005). Adding 200 molar of desferrioxamine trebled PPIX accumulation over the same period of incubation. Cell viability after exposure to light decreased with low doses (0-30 ,umolar) of desferrioxamine (r--0.976, p=0.024). However, higher doses of desferrioxamine (more than 40 molar) seemed to confer a protective effect against PDT. Conclusion-PDT using ALA can be improved by removal of available iron with desferrioxamine. The reason for the protective effect of desferrioxamine seen at higher doses is not clear. (Gut 1997 A similar differential accumulation occurred between mucosa and submucosa. Thus, relative sparing of non-tumour tissue may occur if superficial mucosal lesions were treated in this way. The principle of using ALA to cause accumulation of PPIX results in destruction of superficial tissue after exposure to light6 and has been exploited previously for superficial neoplastic or dysplastic lesions of the skin7 and gastrointestinal tract.8 9 PDT using ALA (ALA/PDT) has some potential, therefore, for superficial lesions involving a large surface area such as Barrett's metaplasia. Barr et allo treated five patients with Barrett's high grade dysplasia using ALA/PDT and the abnormal mucosa was subsequently replaced by squamous epithelium with eradication of dysplastic tissue. An additional advantage of using ALA as a photosensitiser is its short half-life so that skin photosensitivity and other adverse effects should be short-lived.
The purpose of this study was to determine whether the removal of iron from cells, thereby limiting its availability to ferrochelatase in the haem biosynthetic pathway, would result in increased accumulation of PPIX after administration of ALA. This could improve the efficacy or safety of ALA/PDT in gastrooesophageal malignancy. The temperature increase was confirmed to be less than 2°C by using a thermo-couple device during exposure to light. The methyl-tetrazolium assay (MTT, Sigma) was used for the assessment of cell viability. This is a colorimetric assay which has been established as a reliable method of assessing cell viability in PDT studies. 4 Cell viability was assessed at four hours after exposure to light when it was at its trough ( fig 2) . MT, 20 ,lI dissolved in phosphate buffered saline (5 This study has shown that removal of J/cm2. There was a negative linear correlation available iron from a gastric cancer cell line (r=-0-976, p=0.024) between desferrioxamine using desferrioxamine in combination with and cell viability up to 30 ,umolar in the ALA results in increased PPIX accumulation, presence of ALA ( fig 6) . The effect of des-which in turn increased the efficacy of PDT. ferrioxamine on cell viability after exposure to Although desferrioxamine is not a specific light seemed to reverse after 40-60 jxmolar chelator of iron, the addition of iron abrogated desferrioxamine -that is, there was a 'J' shape the effect, supporting the contention that the relation so that at higher doses of desferri-removal of iron had an important role and this oxamine, it seemed to confer a protective effect is certainly a plausible theoretical explanation. on cells against laser light (fig 7) . We were unable In addition, a study by He et al20 on epidermal to demonstrate a free radical scavenging effect of keratinocytes and epidermoid skin cancer cells higher dose desferrioxamine using a thiobarbit-using EDTA as the chelator showed that uric acid (TBA) assay or singlet oxygen quench-removal of iron played an important part in ing using rate of triplet oxygen decay to explain decreasing the activity of ferrochelatase, the J shaped survival curve.
Methods
leading to increased accumulation of PPIX.
The present study also showed that manipulating the availability of iron in this metabolic Discussion pathway could increase cell killing owing to The use of PDT in the treatment of PDT by 30%. This observation has potential gastrointestinal malignancy has attracted much to be exploited clinically. interest.4 8 
15-17 Haematoporphyrins and their
The main advantage of PDT over thermal more pure derivative photofrins have been the laser ablation is the relatively selective destrucmajor photosensitisers studied. 4 16-18 An intriguing observation in this study was that although cell viability on exposure to ALA and light was reduced with addition of desferrioxamine at low doses, it actually recovered again with higher doses, simulating a 'J' shaped viability curve (fig 7) . Although generation of singlet oxygen is the more widely accepted explanation for the mechanism of cytotoxicity with PDT, generation and propagation of free radicals has also been postulated as another possible explanation for the cell damage.28 29 The paradoxical effect of desferrioxamine at high doses may be related to its antioxidant activity at higher doses. 30 We were unable to find evidence of either effect using thiobarbituric acid to detect free radicals30 or triplet oxygen decay as a measure of singlet oxygen quenching.3' This phenomenon will require further study before manipulation of the haem pathway can be undertaken in vivo.
In conclusion, inhibition of ferrochelatase using desferrioxamine in the presence of ALA increased accumulation of PPIX; this, in turn improved the efficacy of ALA/PDT. However, the enhanced effect of ALA/PDT by desferrioxamine seemed to be dose related. At higher doses of desferrioxamine, there was a paradoxical decrease in cell phototoxicity. The explanation for this observation was not due to the anti-oxidation or singlet oxygen trapping property of desferrioxamine at higher doses. Clinical application of the observation using desferrioxamine to enhance ALA/PDT may be possible but will require careful titration of ALA dose in relation to desferrioxamine. Further studies are required.
